| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,425 |
14,675 |
$1.47M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,514 |
2,754 |
$253K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,755 |
4,344 |
$198K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,067 |
8,766 |
$138K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
868 |
722 |
$100K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,469 |
2,891 |
$90K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
959 |
817 |
$45K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
349 |
211 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
319 |
202 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
365 |
284 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
70 |
48 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
45 |
29 |
$3K |
| 87634 |
|
70 |
48 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
76 |
49 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
100 |
84 |
$794.04 |
| 81002 |
|
406 |
335 |
$589.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$184.57 |
| 99000 |
|
14 |
12 |
$0.00 |